Tech Company Financing Transactions

Exagen Diagnostics Funding Round

EPIC Ventures, Signal Peak Ventures and Tullis Health Investors joined a $7 million Series B funding round for Exagen Diagnostics. The round was announced on 6/28/2005.

Transaction Overview

Company Name
Exagen Diagnostics
Announced On
6/28/2005
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series B
Investors

EPIC Ventures (Todd Stevens)

Signal Peak Ventures (Dinesh Patel)

Tullis Health Investors (Thomas Dickerson)

Proceeds Purpose
This round of funding gives Exagen the resources to accelerate our go-tomarket plans and advance our pipeline,

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1261 Liberty Way C
Vista, CA 92081
USA
Phone
(888) 452-1522
Website
www.exagen.com
Email Address
[email protected]
Overview
Exagen Diagnostics is a rheumatology specialty company that focuses on the diagnosis, prognosis and monitoring of autoimmune connective tissue disease.
Profile
Exagen Diagnostics LinkedIn Company Profile
Social Media
Exagen Diagnostics Company Twitter Account
Company News
Exagen Diagnostics News
Facebook
Exagen Diagnostics on Facebook
YouTube
Exagen Diagnostics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ron Rocca
  Ron Rocca LinkedIn Profile  Ron Rocca Twitter Account  Ron Rocca News  Ron Rocca on Facebook
Chief Financial Officer
Kamal Adawi
  Kamal Adawi LinkedIn Profile  Kamal Adawi Twitter Account  Kamal Adawi News  Kamal Adawi on Facebook
Chief Medical Officer
Arthur Weinstein
  Arthur Weinstein LinkedIn Profile  Arthur Weinstein Twitter Account  Arthur Weinstein News  Arthur Weinstein on Facebook
Chief Scientific Officer
Thierry Dervieux
  Thierry Dervieux LinkedIn Profile  Thierry Dervieux Twitter Account  Thierry Dervieux News  Thierry Dervieux on Facebook
Vice President
Brian Littlefield
  Brian Littlefield LinkedIn Profile  Brian Littlefield Twitter Account  Brian Littlefield News  Brian Littlefield on Facebook
Vice President
Tami Powell
  Tami Powell LinkedIn Profile  Tami Powell Twitter Account  Tami Powell News  Tami Powell on Facebook
VP - Finance
Mark Hazeltine
  Mark Hazeltine LinkedIn Profile  Mark Hazeltine Twitter Account  Mark Hazeltine News  Mark Hazeltine on Facebook
VP - Marketing
Brian McEvilly
  Brian McEvilly LinkedIn Profile  Brian McEvilly Twitter Account  Brian McEvilly News  Brian McEvilly on Facebook
VP - Operations
Claudia Ibarra
  Claudia Ibarra LinkedIn Profile  Claudia Ibarra Twitter Account  Claudia Ibarra News  Claudia Ibarra on Facebook
VP - Sales
John Wegener
  John Wegener LinkedIn Profile  John Wegener Twitter Account  John Wegener News  John Wegener on Facebook

 

 

Browse more venture capital transactions:

Prev: 6/28/2005: Cloverleaf Communications venture capital transaction
Next: 6/28/2005: Torax Medical venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.